Shuo Yuan

1.3k total citations · 2 hit papers
73 papers, 933 citations indexed

About

Shuo Yuan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Shuo Yuan has authored 73 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Shuo Yuan's work include Synthesis and biological activity (8 papers), Catalytic C–H Functionalization Methods (6 papers) and Chemical Reactions and Isotopes (4 papers). Shuo Yuan is often cited by papers focused on Synthesis and biological activity (8 papers), Catalytic C–H Functionalization Methods (6 papers) and Chemical Reactions and Isotopes (4 papers). Shuo Yuan collaborates with scholars based in China, New Zealand and United States. Shuo Yuan's co-authors include Bin Yu, Hong‐Min Liu, Jian Song, Sai‐Yang Zhang, Junbiao Chang, Yi‐Ru Bai, Jingya Zhang, Shi‐Wu Chen, Dandan Shen and Lirong Zhang and has published in prestigious journals such as Chemical Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Shuo Yuan

63 papers receiving 915 citations

Hit Papers

Recent development of multi-target VEGFR-2 inhibitors for... 2023 2026 2024 2025 2023 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
    2023 93 citations Xiujuan Liu, Haojie Zhang et al. Bioorganic Chemistry profile →
  2. Annual review of PROTAC degraders as anticancer agents in 2022
    2024 61 citations Xiao Wang, Yi‐Ru Bai et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Yuan China 18 415 383 133 51 50 73 933
Nulgumnalli Manjunathaiah Raghavendra India 16 398 1.0× 324 0.8× 166 1.2× 71 1.4× 35 0.7× 46 833
Meng Zhou China 21 583 1.4× 497 1.3× 135 1.0× 96 1.9× 70 1.4× 75 1.2k
Sowjanya Thatikonda India 17 294 0.7× 209 0.5× 93 0.7× 56 1.1× 34 0.7× 27 857
Denis Thiolat France 16 332 0.8× 336 0.9× 148 1.1× 57 1.1× 70 1.4× 19 1.3k
Marwa Sharaky Egypt 15 262 0.6× 272 0.7× 92 0.7× 37 0.7× 52 1.0× 78 892
Thikryat Neamatallah Saudi Arabia 18 301 0.7× 200 0.5× 86 0.6× 73 1.4× 42 0.8× 41 865
Mohamed A. Tantawy Egypt 21 422 1.0× 602 1.6× 124 0.9× 88 1.7× 47 0.9× 50 1.2k
Shelly Pathania India 15 308 0.7× 729 1.9× 103 0.8× 93 1.8× 27 0.5× 25 1.1k
Chih‐Shiang Chang Taiwan 18 398 1.0× 269 0.7× 81 0.6× 51 1.0× 50 1.0× 50 853
Maria Antonietta Occhiuzzi Italy 16 263 0.6× 148 0.4× 98 0.7× 47 0.9× 39 0.8× 35 653

Countries citing papers authored by Shuo Yuan

Since Specialization
Citations

This map shows the geographic impact of Shuo Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Yuan more than expected).

Fields of papers citing papers by Shuo Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Yuan. The network helps show where Shuo Yuan may publish in the future.

Co-authorship network of co-authors of Shuo Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Yuan. A scholar is included among the top collaborators of Shuo Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Yuan. Shuo Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qian, Zhuo, Yi‐Ru Bai, Wenjuan Zhou, et al.. (2025). The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia. Bioorganic Chemistry. 156. 108189–108189. 2 indexed citations
3.
4.
5.
Song, Jian, Shenghui Wang, Xiao Wang, et al.. (2024). N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters. 36(2). 109678–109678. 5 indexed citations
6.
Liu, Xiujuan, Haojie Zhang, Lei Cheng, et al.. (2023). Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorganic Chemistry. 133. 106425–106425. 93 indexed citations breakdown →
7.
Jin, Gang, et al.. (2023). Targeting histone deacetylases for heart diseases. Bioorganic Chemistry. 138. 106601–106601. 8 indexed citations
8.
Li, Hongli, Lulu Dong, Qianyu Li, et al.. (2023). A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. Molecules. 28(3). 1141–1141. 11 indexed citations
9.
Yuan, Shuo, et al.. (2023). Source of IC power consumption and low power design. Theoretical and Natural Science. 28(1). 116–122. 1 indexed citations
10.
Yuan, Shuo, et al.. (2023). New drug approvals for 2022: Synthesis and clinical applications. Medicinal Research Reviews. 43(6). 2352–2391. 17 indexed citations
11.
Bai, Yi‐Ru, Weiguang Yang, Dandan Shen, et al.. (2023). The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases. European Journal of Medicinal Chemistry. 258. 115606–115606. 23 indexed citations
12.
Yuan, Shuo, Hui Liu, Shengnan Zhang, et al.. (2022). New drug approvals for 2021: Synthesis and clinical applications. European Journal of Medicinal Chemistry. 245. 114898–114898. 34 indexed citations
13.
Yuan, Shuo, Jingya Zhang, Donghui Wei, et al.. (2021). Cu(OTf)2-Catalyzed Intramolecular Radical Cascade Reactions for the Diversity-Oriented Synthesis of Quinoline-Annulated Polyheterocyclic Frameworks. Organic Letters. 23(4). 1445–1450. 21 indexed citations
14.
Yuan, Shuo, et al.. (2021). New drug approvals for 2020: Synthesis and clinical applications. European Journal of Medicinal Chemistry. 215. 113284–113284. 41 indexed citations
15.
Yuan, Shuo, Bo Wang, Qing-Qing Dai, et al.. (2021). Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors. Journal of Medicinal Chemistry. 64(19). 14895–14911. 41 indexed citations
16.
Yuan, Shuo, Bin Yu, & Hong‐Min Liu. (2020). New drug approvals for 2019: Synthesis and clinical applications. European Journal of Medicinal Chemistry. 205. 112667–112667. 48 indexed citations
17.
Yuan, Shuo, Junbiao Chang, & Bin Yu. (2020). Construction of Biologically Important Biaryl Scaffolds through Direct C–H Bond Activation: Advances and Prospects. Topics in Current Chemistry. 378(2). 23–23. 60 indexed citations
18.
Yuan, Shuo, et al.. (2020). Synthesis of new tetracyclic benzodiazepine-fused isoindolinones using recyclable mesoporous silica nanoparticles. Chemical Communications. 56(77). 11461–11464. 11 indexed citations
19.
Yuan, Shuo, et al.. (2020). Palladium-Catalyzed Ligand-Free Double Cyclization Reactions for the Synthesis of 3-(1′-Indolyl)-phthalides. Organic Letters. 22(3). 814–817. 20 indexed citations
20.
Wang, Peixia, Chunfeng Xie, Lijun An, et al.. (2019). Bioactive Diterpenoids from the Stems of Euphorbia royleana. Journal of Natural Products. 82(2). 183–193. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nulgumnalli Manjunathaiah Raghavendra Breakdown of academic impact, for papers by Meng Zhou Breakdown of academic impact, for papers by Sowjanya Thatikonda Breakdown of academic impact, for papers by Denis Thiolat Breakdown of academic impact, for papers by Marwa Sharaky Breakdown of academic impact, for papers by Thikryat Neamatallah Breakdown of academic impact, for papers by Mohamed A. Tantawy Breakdown of academic impact, for papers by Shelly Pathania Breakdown of academic impact, for papers by Chih‐Shiang Chang Breakdown of academic impact, for papers by Maria Antonietta Occhiuzzi
Rankless by CCL
2026